Ny-Eso-1 Protein Formulated With Immunostimulatory Complexes (Iscom (R) Adjuvant) In Patients With Minimal Residual Disease Induces A Broad-Based Immune Response Involving Cd4 & Cd8 T Lymphocytes And High Titered Antibody.

Js Cebon,Id Davis,W Chen, P Parente,H Jackson, M Shackleton,W Hopkins, Qy Chen,R Murphy, Ty Tai,N Dimopoulos, A Scott,G Mcarthur,D Macgregor, L Miloradovic, S Green, E Maraskovsky, A Cuthbertson,D Maher, S Mitchell, G Ritter, E Stockert,Ew Hoffman, L Pugliese,Lj Old

CLINICAL CANCER RESEARCH(2003)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要